Overview

Dashboard News

UBS maintains neutral rating for Schott Pharma with target price of 32.60 euros

UBS has maintained a "Neutral" rating for Schott Pharma AG, setting a target price of €32.60 ahead of the 2023/24 financial year results. Analyst Olivier Calvet anticipates a gradual recovery in the company's mass business, which constitutes about half of its sales, in 2025.
boerse.de
Euro SCHOTT Pharma AG & Co. KGaA CHE DEU Olivier Calvet
TradFi, Market Report
18:43 25.11.2024

creditors engage in debt talks with commscope for maturity extension

A group of creditors, including Apollo Global Management Inc. and Monarch Alternative Capital, has initiated confidential discussions with CommScope Holding Co. regarding a potential extension of debt maturities. These talks are conducted under nondisclosure agreements, allowing for the exchange of private information.
Bloomberg.com
CommScope Holding Company, Inc. Apollo Global Management, Inc. USA
Finance & Economy, Market Report
18:41 25.11.2024

Brussels plans to reduce green regulations amid economic challenges

Brussels is set to reduce green regulations to bolster Europe's struggling economy, while BusinessEurope expresses concerns that a potential Trump victory could harm green exports due to proposed import tariffs, limiting U.S. market access and intensifying competition with China. Meanwhile, an EU fraud investigation into a €46 million waste treatment project in Cyprus faces bureaucratic delays, raising issues for Costas Kadis as he prepares for his role as EU commissioner amidst a decade-old environmental dispute in Limassol. Kadis, a conservation biologist, has extensive ministerial experience spanning 25 years.
POLITICO
Euro Businesseurope CYP Costas Kadis
Regulatory & Legal, News Article
18:33 25.11.2024

hims and hers shares soar on trump fda pick support

Hims & Hers Health Inc. shares surged by up to 18%, reaching record highs, following the news of President-elect Donald Trump nominating Marty Makary to lead the FDA. Hunterbrook Media highlighted that Makary could be a significant ally for the company, which is involved in selling compounded GLP-1 weight loss drugs. Hunterbrook Capital has shifted its position to long Hims shares, reversing a previous short bet.
bloomberg.com
HIMS & HERS HEALTH INC Sesame Inc. USA Marty Makary
Healthcare, Market Report
18:32 25.11.2024

chott pharma maintains neutral rating amid advanced drug delivery solutions

SCHOTT Pharma AG & Co KGaA, based in Germany, specializes in advanced drug containment and delivery solutions for the pharmaceutical and biotechnology sectors. The company offers a comprehensive range of products, including pharmaceutical syringes, cartridges, vials, and ampoules, positioning itself as a leader in the injectable drugs market. UBS has maintained a neutral rating on the company.
Zonebourse
Euro United States Dollar SCHOTT Pharma AG & Co. KGaA DEU Show more
TradFi, Market Report
18:30 25.11.2024

ECB urged to proceed cautiously with interest rate cuts, says Nagel

Joachim Nagel, a member of the European Central Bank's Governing Council, cautioned against hasty interest rate cuts despite inflation trends moving toward the ECB's target. He noted that as wage pressures ease, inflation in services is expected to decline, signaling a potential return to the 2% target.
Bloomberg.com
Euro European Central Bank DEU Joachim Nagel
Finance & Economy, Market Report
18:30 25.11.2024

Cortica secures 80 million to enhance autism care and expand services

Cortica, a provider for autistic and neurodivergent children, has secured $80 million in funding co-led by Morgan Health and Nexus NeuroTech Ventures to expand its value-based care contracts and services across eight states. The investment aims to enhance evaluation, diagnosis, and treatment while improving clinical outcomes, addressing the growing demand for integrated care solutions. Cortica's model, which includes a multidisciplinary team, has shown to reduce therapy volumes and associated costs while improving patient outcomes.
Fierce Healthcare
JPMorgan Chase & Co. USA Neil Hattangadi Dan Mendelson
Healthcare, Press Release
18:29 25.11.2024

ubs shares rise slightly as trading volume increases

UBS shares rose 0.1% to CHF 28.34, with a daily high of CHF 28.75, amidst a trading volume of 1,878,482 shares. The stock's 52-week high is CHF 29.57, while the low stands at CHF 22.53. UBS reported Q3 earnings of CHF 0.39 per share and revenues of CHF 18.86 billion, with expectations for a dividend of USD 0.819 this year.
finanzen.ch
Swiss Franc United States Dollar UBS CHE Carsten Spohr
TradFi, Market Report
18:25 25.11.2024

healthcare bpo market analysis and strategic insights for business growth

Prudent Markets offers comprehensive market research and consulting services, focusing on the Healthcare BPO market across various regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The report covers market dynamics, competitive analysis, and strategic insights, providing clients with essential data to support critical business decisions. Customization options are available to meet specific client needs, ensuring tailored insights for effective market strategies.
openPR.com
USA SWE CAN FRA DEU ITA MEX AUS ZAF IND ESP CHN JPN GBR BRA Allan Carter Show more
Finance & Economy, Market Report
18:19 25.11.2024

Cramer sets bullish target for biopharmaceutical stock ahead of earnings report

On November 25, 2024, Cramer sets a bullish target for a pharmaceutical stock, while Jim and Jeff discuss their investment strategies in a biopharmaceutical company. They also consider increasing their positions in this stock and analyze expectations for an upcoming retail stock's earnings.
CNBC
Jim Cramer Jeff Jim Carrey Jeffrey Dean Morgan Jim Cramer Show more
Finance & Economy, Transcript
18:10 25.11.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Central Bank Actions Market Sentiment Analysis Decentralized Finance (DeFi) Innovations Hedge Funds & Private Equity Cryptocurrency Regulations Market Analysis and Predictions Inflation Rates & CPI Data Anti-Money Laundering (AML) Regulations Banking Regulations Cryptocurrency & Blockchain Regulations Tokenomics and Crypto Economics Employment Reports Banking & Investment Regulations ESG & Sustainable Finance Regulations Mergers & Acquisitions Community Building in Blockchain Gaming Cryptocurrency Developments
Countries:
USA CHE IND CHN JPN SGP FRA KOR RUS GBR KEN DEU BRA PHL CAN PRK ARE KAZ KHM IRL
Companies:
Apple Inc. JPMorgan Chase & Co. Bank of America Corporation Kraken Energy Corp. The Goldman Sachs Group, Inc. Solana USD NVIDIA Corporation Citigroup Inc. Morgan Stanley Coinbase Global, Inc. Bitwise Bitcoin ETF Ripples USD Grayscale Bitcoin Trust ETF Novartis AG BlackRock, Inc. Credit Suisse Real Estate Fund Siat Santiment Network Token USD BTG Pactual Chile S.A. Administradora General De Fondos - Liquidez Alternativa Fund Ethereum USD Ripple USD USD
Currencies:
United States Dollar Japanese Yen Swiss Franc Indian Rupee Euro Chinese Yuan British Pound Sterling Philippine Peso Malagasy Ariary Singapore Dollar Australian Dollar Hong Kong Dollar Armenian Dram
People:
Donald Trump Ali Martinez Elon Musk Joe Biden Peter Brandt John Williams Javon Marks Letitia James Brad Garlinghouse Shytoshi Kusama Raoul Pal Yoon Suk Yeol Carl Runefelt Neel Kashkari Austan Dean Goolsbee David O. Sacks Scott Bessent Greg Cipolaro Jeffrey Schmid Paul Atkins

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings